Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,270 publicly listed stocks with a combined market cap of $1.89 Trillion. Spero Therapeutics Inc leads the sector with a market cap of $147.65 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.89 Trillion
Companies Listed
1,270
Largest Company
Spero Therapeutics Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 601 |
Spero Therapeutics Inc
NASDAQ:SPRO |
$147.65 Million | $147.65 Million | USA | $2.77 | -4.81% | +1.09% | 21.58 Million |
| 602 |
Compugen
TA:CGEN |
$146.52 Million | ILA54.65 Billion | Israel | ILA584.30 | -2.45% | -9.83% | 1.34 Million |
| 603 |
Medigen Biotechnology
TWO:3176 |
$146.15 Million | NT$4.64 Billion | Taiwan | NT$33.30 | -0.15% | +7.59% | 28.28 Million |
| 604 |
Molecular Partners AG
SW:MOLN |
$145.86 Million | CHF115.37 Million | Switzerland | CHF3.15 | +3.96% | +0.32% | 423.82K |
| 605 |
Mersana Therapeutics Inc
NASDAQ:MRSN |
$145.36 Million | $145.36 Million | USA | $29.08 | +0.14% | -0.07% | 2.50 Million |
| 606 |
NIBEC Co. Ltd
KQ:138610 |
$144.22 Million | ₩212.82 Billion | Korea | ₩18820.00 | -0.42% | +7.97% | 1.52 Million |
| 607 |
Oncolytics Biotech Inc
TO:ONC |
$142.51 Million | CA$197.01 Million | Canada | CA$14.90 | -1.32% | -19.89% | 4.94 Million |
| 608 |
PROQR THERAPEUTICS EO-04
F:0PQ |
$142.34 Million | €121.75 Million | Germany | €1.31 | +8.51% | +2.26% | 12.43K |
| 609 |
Whitehawk Therapeutics, Inc.
NASDAQ:WHWK |
$141.39 Million | $141.39 Million | USA | $4.17 | +1.71% | +3.73% | 11.73 Million |
| 610 |
TIZIANA LIFE SCIENCES LTD
F:0RP |
$141.34 Million | €120.90 Million | Germany | €0.95 | -15.93% | -15.93% | 70.93K |
| 611 |
Prelude Therapeutics Inc
NASDAQ:PRLD |
$140.19 Million | $140.19 Million | USA | $4.20 | -5.83% | +9.38% | 7.53 Million |
| 612 |
Tiziana Life Sciences Ltd
NASDAQ:TLSA |
$139.99 Million | $139.99 Million | USA | $1.10 | -0.90% | -9.84% | 6.64 Million |
| 613 |
Heidelberg Pharma AG
F:HPHA |
$138.38 Million | €118.36 Million | Germany | €2.53 | +0.00% | -3.44% | 117.00 |
| 614 |
Vaxart Inc
NASDAQ:VXRT |
$136.71 Million | $136.71 Million | USA | $0.57 | +0.89% | -8.87% | 6.21 Million |
| 615 |
Tenaya Therapeutics Inc
NASDAQ:TNYA |
$136.66 Million | $136.66 Million | USA | $0.68 | -5.38% | -0.93% | 86.62 Million |
| 616 |
Genelux Corporation Common Stock
NASDAQ:GNLX |
$135.87 Million | $135.87 Million | USA | $3.03 | +0.33% | +3.41% | 3.76 Million |
| 617 |
Vytrus Biotech S.A.
MC:VYT |
$135.30 Million | €115.73 Million | Spain | €18.00 | +4.05% | +9.09% | 140.82K |
| 618 |
Genovis AB (publ.)
ST:GENO |
$135.08 Million | Skr1.26 Billion | Sweden | Skr19.00 | -1.55% | -2.06% | 1.14 Million |
| 619 |
Corbus Pharmaceuticals Holding
NASDAQ:CRBP |
$133.75 Million | $133.75 Million | USA | $7.88 | -5.29% | +4.23% | 16.06 Million |
| 620 |
Innate Pharma
NASDAQ:IPHA |
$133.24 Million | $133.24 Million | USA | $1.79 | +0.00% | +1.70% | 3.63 Million |
| 621 |
MOLECULAR PARTNERS ADS/1
F:6ML0 |
$133.19 Million | €113.92 Million | Germany | €3.54 | -3.80% | +0.00% | 17.40K |
| 622 |
VYTRUS BIOTECH EO -01
F:V5P |
$131.54 Million | €112.51 Million | Germany | €18.30 | +7.33% | +13.31% | 0.00 |
| 623 |
Fate Therapeutics Inc
NASDAQ:FATE |
$131.50 Million | $131.50 Million | USA | $1.90 | -5.47% | -0.52% | 99.96 Million |
| 624 |
Tharimmune Inc.
NASDAQ:THAR |
$130.84 Million | $130.84 Million | USA | $3.31 | -5.70% | +0.00% | 15.04 Million |
| 625 |
TuHURA Biosciences Inc
NASDAQ:HURA |
$128.64 Million | $128.64 Million | USA | $2.23 | -1.76% | +9.05% | 11.96 Million |
| 626 |
Spruce Biosciences, Inc. Common Stock
NASDAQ:SPRB |
$127.28 Million | $127.28 Million | USA | $47.10 | -5.62% | -4.50% | 1.27 Million |
| 627 |
Alpha Cognition Inc
NASDAQ:ACOG |
$127.19 Million | $127.19 Million | USA | $6.01 | +0.33% | -0.17% | 889.31K |
| 628 |
ADC Therapeutics SA
NYSE:ADCT |
$126.72 Million | $126.72 Million | USA | $1.00 | -5.11% | +1.90% | 63.73 Million |
| 629 |
Equillium Inc
NASDAQ:EQ |
$126.05 Million | $126.05 Million | USA | $2.75 | -1.79% | -0.72% | 23.69 Million |
| 630 |
Connect Biopharma Holdings Ltd
NASDAQ:CNTB |
$125.30 Million | $125.30 Million | USA | $1.99 | -3.40% | -9.55% | 5.56 Million |
| 631 |
Agenus Inc
NASDAQ:AGEN |
$124.09 Million | $124.09 Million | USA | $2.98 | -8.31% | -5.10% | 14.73 Million |
| 632 |
Xlife Sciences AG
SW:XLS |
$122.27 Million | CHF96.71 Million | Switzerland | CHF24.00 | -6.25% | +4.35% | 249.58K |
| 633 |
vTv Therapeutics Inc
NASDAQ:VTVT |
$119.97 Million | $119.97 Million | USA | $32.24 | -3.88% | +0.56% | 1.09 Million |
| 634 |
Satellos Bioscience Inc. Common Stock
NASDAQ:MSLE |
$119.78 Million | $119.78 Million | USA | $5.75 | +0.00% | -5.43% | 744.45K |
| 635 |
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS |
$119.73 Million | $119.73 Million | USA | $0.78 | -8.71% | +15.82% | 49.96 Million |
| 636 |
Inhibikase Therapeutics Inc
NASDAQ:IKT |
$119.23 Million | $119.23 Million | USA | $1.67 | +0.00% | +3.09% | 15.67 Million |
| 637 |
Satellos Bioscience Inc.
TO:MSCL |
$118.89 Million | CA$164.36 Million | Canada | CA$7.89 | -1.38% | -7.29% | 283.23K |
| 638 |
Jyong Biotech Ltd. Ordinary Shares
NASDAQ:MENS |
$118.77 Million | $118.77 Million | USA | $1.60 | +0.00% | -20.00% | 2.15 Million |
| 639 |
Captor Therapeutics S.A.
WAR:CTX |
$117.65 Million | zł427.48 Million | Poland | zł77.60 | -0.51% | -0.51% | 99.67K |
| 640 |
INNATE PHARMA SP.ADR/1
F:IDDA |
$116.15 Million | €99.35 Million | Germany | €1.06 | -9.40% | -26.90% | 6.23K |
| 641 |
Leap Therapeutics Inc
NASDAQ:LPTX |
$116.14 Million | $116.14 Million | USA | $2.05 | +368.57% | +391.14% | 817.45 Million |
| 642 |
InflaRx N.V
F:IF0 |
$115.62 Million | €98.90 Million | Germany | €1.37 | -2.29% | -22.27% | 55.26K |
| 643 |
CANBRIDGE PHARM.DL-00001
F:MF1 |
$115.51 Million | €98.80 Million | Germany | €0.20 | +0.00% | +20.00% | 0.00 |
| 644 |
OBI Pharma
TWO:4174 |
$115.37 Million | NT$3.66 Billion | Taiwan | NT$27.85 | +0.00% | -2.62% | 10.64 Million |
| 645 |
Innate Pharma
PA:IPH |
$115.22 Million | €98.56 Million | France | €1.55 | +0.00% | +0.00% | 16.52 Million |
| 646 |
NeOnc Technologies Holdings, Inc. Common Stock
NASDAQ:NTHI |
$114.98 Million | $114.98 Million | USA | $5.18 | +14.86% | +15.37% | 2.00 Million |
| 647 |
Repare Therapeutics Inc
NASDAQ:RPTX |
$114.24 Million | $114.24 Million | USA | $2.65 | +0.76% | +2.71% | 37.69 Million |
| 648 |
Codexis Inc
NASDAQ:CDXS |
$112.91 Million | $112.91 Million | USA | $2.48 | -0.40% | -4.80% | 17.03 Million |
| 649 |
Biosolution Co.Ltd
KQ:086820 |
$112.51 Million | ₩166.02 Billion | Korea | ₩6880.00 | -0.58% | +4.72% | 4.26 Million |
| 650 |
Sagittarius Life Science
TWO:3205 |
$112.36 Million | NT$3.57 Billion | Taiwan | NT$52.80 | -1.68% | -1.12% | 6.49 Million |
| 651 |
Cognition Therapeutics Inc
NASDAQ:CGTX |
$111.23 Million | $111.23 Million | USA | $1.26 | +4.13% | +4.13% | 25.23 Million |
| 652 |
Synergy Innovation Co. Ltd
KQ:048870 |
$110.88 Million | ₩163.61 Billion | Korea | ₩1857.00 | -2.37% | +10.40% | 8.37 Million |
| 653 |
Arcticzymes Technologies ASA
OL:AZT |
$110.71 Million | Nkr1.05 Billion | Norway | Nkr20.60 | +1.98% | -1.44% | 862.48K |
| 654 |
PepGen Ltd
NASDAQ:PEPG |
$109.98 Million | $109.98 Million | USA | $1.59 | +3.92% | +17.78% | 16.57 Million |
| 655 |
Milestone Pharmaceuticals Inc
NASDAQ:MIST |
$109.87 Million | $109.87 Million | USA | $1.29 | -1.53% | +4.88% | 36.26 Million |
| 656 |
Genovate Biotechnology Co Ltd
TWO:4130 |
$109.86 Million | NT$3.49 Billion | Taiwan | NT$25.50 | -0.78% | -1.35% | 3.63 Million |
| 657 |
Coya Therapeutics, Inc. Common Stock
NASDAQ:COYA |
$108.84 Million | $108.84 Million | USA | $4.82 | -1.43% | +5.93% | 3.84 Million |
| 658 |
Alterity Therapeutics Ltd
AU:ATH |
$108.75 Million | AU$153.70 Million | Australia | AU$0.53 | +3.92% | +26.19% | 70.78 Million |
| 659 |
Polaryx Therapeutics, Inc. Common Stock
NASDAQ:PLYX |
$108.42 Million | $108.42 Million | USA | $2.29 | -2.14% | -6.91% | 8.45 Million |
| 660 |
Nykode Therapeutics ASA
OL:NYKD |
$108.07 Million | Nkr1.03 Billion | Norway | Nkr3.15 | +0.32% | -0.94% | 20.07 Million |
| 661 |
Aldeyra The
NASDAQ:ALDX |
$107.09 Million | $107.09 Million | USA | $1.78 | +1.14% | +2.30% | 24.29 Million |
| 662 |
enGene Holdings Inc. Common Stock
NASDAQ:ENGN |
$106.51 Million | $106.51 Million | USA | $1.75 | -1.13% | +6.06% | 36.04 Million |
| 663 |
Hillevax Inc
NASDAQ:HLVX |
$104.76 Million | $104.76 Million | USA | $2.09 | +0.00% | -0.48% | 19.87 Million |
| 664 |
Abionyx Pharma SA
PA:ABNX |
$104.56 Million | €89.43 Million | France | €2.54 | -5.76% | -7.48% | 3.75 Million |
| 665 |
Kalaris Therapeutics, Inc.
NASDAQ:KLRS |
$103.73 Million | $103.73 Million | USA | $4.37 | +2.34% | +4.80% | 1.84 Million |
| 666 |
Active Biotech AB
ST:ACTI |
$103.60 Million | Skr962.66 Million | Sweden | Skr5.86 | -3.54% | -8.01% | 424.00 Million |
| 667 |
Verrica Pharmaceuticals Inc
NASDAQ:VRCA |
$103.07 Million | $103.07 Million | USA | $6.00 | +3.27% | +0.17% | 1.24 Million |
| 668 |
SYN-Tech Chem & Pharm Co Ltd
TWO:1777 |
$101.71 Million | NT$3.23 Billion | Taiwan | NT$72.40 | +0.00% | +1.69% | 768.38K |
| 669 |
Recce Pharmaceuticals Ltd
AU:RCE |
$101.28 Million | AU$143.15 Million | Australia | AU$0.50 | -1.98% | -3.88% | 2.59 Million |
| 670 |
GREEN CROSS WellBeing Corporation
KQ:234690 |
$101.26 Million | ₩149.41 Billion | Korea | ₩8420.00 | +3.06% | +5.51% | 4.95 Million |
| 671 |
Vivani Medical Inc.
NASDAQ:VANI |
$100.90 Million | $100.90 Million | USA | $1.17 | +3.54% | +1.74% | 4.57 Million |
| 672 |
MEI Pharma Inc
NASDAQ:MEIP |
$100.81 Million | $100.81 Million | USA | $3.07 | +10.43% | -36.70% | 26.47 Million |
| 673 |
Darwin AG
XETRA:7V0 |
$100.20 Million | €85.71 Million | Germany | €8.30 | +11.41% | +27.69% | 49.69K |
| 674 |
STARPHARMA HLDG.SP.ADR/10
F:PQ6A |
$99.13 Million | €84.79 Million | Germany | €4.40 | -3.51% | +20.22% | 0.00 |
| 675 |
Cibus Global LLC
NASDAQ:CBUS |
$97.17 Million | $97.17 Million | USA | $1.31 | +3.15% | +6.50% | 6.42 Million |
| 676 |
Black Diamond Therapeutics Inc
NASDAQ:BDTX |
$96.27 Million | $96.27 Million | USA | $1.68 | -2.33% | -9.19% | 50.30 Million |
| 677 |
Adverum Biotechnologies Inc
NASDAQ:ADVM |
$96.26 Million | $96.26 Million | USA | $4.36 | +0.00% | +3.81% | 11.22 Million |
| 678 |
Immunoprecise Antibodies Ltd
NASDAQ:IPA |
$95.54 Million | $95.54 Million | USA | $2.07 | +7.25% | -25.00% | 41.05 Million |
| 679 |
Seer Inc
NASDAQ:SEER |
$94.02 Million | $94.02 Million | USA | $1.71 | +0.00% | -4.47% | 5.28 Million |
| 680 |
Genexine Inc
KQ:095700 |
$94.00 Million | ₩138.71 Billion | Korea | ₩3050.00 | +1.84% | +7.39% | 7.81 Million |
| 681 |
Infant Bacterial Therapeutics AB (publ)
ST:IBT-B |
$93.86 Million | Skr872.22 Million | Sweden | Skr67.00 | +0.75% | +12.61% | 270.83K |
| 682 |
Bioton S.A.
WAR:BIO |
$93.82 Million | zł340.88 Million | Poland | zł3.97 | -0.25% | -1.00% | 1.73 Million |
| 683 |
Adocia
PA:ADOC |
$93.64 Million | €80.10 Million | France | €4.45 | +1.14% | +6.26% | 5.27 Million |
| 684 |
Bonus Biogroup
TA:BONS |
$93.00 Million | ILA34.69 Billion | Israel | ILA29.70 | -5.11% | -19.07% | 27.34 Million |
| 685 |
Rallybio Corp
NASDAQ:RLYB |
$92.22 Million | $92.22 Million | USA | $15.90 | +0.00% | -0.06% | 1.74 Million |
| 686 |
Apex Biotechnology Corp
TW:1733 |
$92.11 Million | NT$2.92 Billion | Taiwan | NT$29.25 | -0.34% | +2.27% | 5.85 Million |
| 687 |
Ryvu Therapeutics SA
WAR:RVU |
$91.37 Million | zł332.01 Million | Poland | zł14.36 | -2.58% | -9.34% | 1.93 Million |
| 688 |
Q32 Bio Inc
NASDAQ:QTTB |
$91.06 Million | $91.06 Million | USA | $12.75 | -0.86% | +5.99% | 33.09 Million |
| 689 |
BIOCELTIX S.A. ZY -10
F:XI3 |
$89.73 Million | €76.75 Million | Germany | €17.68 | -2.96% | +2.91% | 0.00 |
| 690 |
OSE Pharma SA
PA:OSE |
$88.43 Million | €75.64 Million | France | €3.82 | -4.31% | +7.43% | 7.89 Million |
| 691 |
GlycoNex
TWO:4168 |
$87.55 Million | NT$2.78 Billion | Taiwan | NT$25.10 | -2.33% | +0.00% | 16.59 Million |
| 692 |
Terns Pharmaceuticals Inc
NASDAQ:TERN |
$87.01 Million | $87.01 Million | USA | $0.80 | +0.00% | +63.27% | 80.93 Million |
| 693 |
Pyxis Oncology Inc
NASDAQ:PYXS |
$86.55 Million | $86.55 Million | USA | $1.75 | +0.57% | +3.55% | 12.93 Million |
| 694 |
Cardiff Oncology Inc
NASDAQ:CRDF |
$86.14 Million | $86.14 Million | USA | $1.26 | -11.27% | -16.00% | 39.31 Million |
| 695 |
Intech Biopharm Ltd
TWO:6461 |
$85.97 Million | NT$2.73 Billion | Taiwan | NT$15.30 | -1.92% | -3.16% | 5.21 Million |
| 696 |
Pelthos Therapeutics Inc.
NYSE MKT:PTHS |
$85.55 Million | $85.55 Million | USA | $26.66 | -1.62% | -3.72% | 583.37K |
| 697 |
Dimerix Ltd
AU:DXB |
$84.96 Million | AU$120.08 Million | Australia | AU$0.20 | +21.21% | +14.29% | 57.46 Million |
| 698 |
Neuraxis, Inc.
NYSE MKT:NRXS |
$84.91 Million | $84.91 Million | USA | $7.38 | -0.67% | -11.62% | 4.63 Million |
| 699 |
ImmuCell Corporation
NASDAQ:ICCC |
$84.86 Million | $84.86 Million | USA | $9.38 | -1.57% | -3.30% | 707.58K |
| 700 |
Anixa Biosciences Inc
NASDAQ:ANIX |
$84.38 Million | $84.38 Million | USA | $2.61 | +5.24% | +6.10% | 2.84 Million |
| 701 |
Chunghwa Chemical Synthesis & Biotech Co Ltd
TW:1762 |
$84.09 Million | NT$2.67 Billion | Taiwan | NT$34.70 | -1.84% | -13.90% | 22.03 Million |
| 702 |
Immutep Ltd ADR
NASDAQ:IMMP |
$84.03 Million | $84.03 Million | USA | $0.57 | -3.65% | +4.94% | 807.12 Million |
| 703 |
Biomea Fusion Inc
NASDAQ:BMEA |
$83.87 Million | $83.87 Million | USA | $1.16 | -3.33% | +0.87% | 26.32 Million |
| 704 |
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELO |
$83.22 Million | $83.22 Million | USA | $1.28 | -0.78% | +0.00% | 2.18 Million |
| 705 |
Brii Biosciences Limited
F:7SS |
$83.05 Million | €71.04 Million | Germany | €0.10 | -3.43% | -9.63% | 1.02K |
| 706 |
Helix BioPharma Corp.
TO:HBP |
$82.88 Million | CA$114.57 Million | Canada | CA$1.50 | +0.67% | -1.96% | 18.98K |
| 707 |
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ:ARTV |
$82.80 Million | $82.80 Million | USA | $8.91 | -2.94% | +31.03% | 14.29 Million |
| 708 |
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD |
$81.00 Million | $81.00 Million | USA | $3.72 | -3.12% | +3.62% | 4.19 Million |
| 709 |
Rein Therapeutics Inc
NASDAQ:RNTX |
$80.67 Million | $80.67 Million | USA | $0.95 | +0.27% | -0.39% | 12.81 Million |
| 710 |
XSpray Pharma AB
ST:XSPRAY |
$80.52 Million | Skr748.23 Million | Sweden | Skr15.78 | +3.82% | -12.04% | 6.54 Million |
| 711 |
Champions Oncology Inc
NASDAQ:CSBR |
$79.85 Million | $79.85 Million | USA | $6.88 | +8.52% | +21.99% | 224.62K |
| 712 |
Fortress Biotech Inc
NASDAQ:FBIO |
$79.39 Million | $79.39 Million | USA | $2.93 | +2.45% | +2.81% | 11.22 Million |
| 713 |
VIVANI MED.INC. NEW O.N.
F:U5P |
$79.34 Million | €67.86 Million | Germany | €0.92 | +5.75% | -1.08% | 0.00 |
| 714 |
Sutro Biopharma
NASDAQ:STRO |
$79.09 Million | $79.09 Million | USA | $28.17 | -6.72% | +10.86% | 7.52 Million |
| 715 |
Nanoform Finland Plc
HE:NANOFH |
$78.90 Million | €67.49 Million | Finland | €0.87 | -1.48% | -2.70% | 6.75 Million |
| 716 |
Actinogen Medical Ltd
AU:ACW |
$78.71 Million | AU$111.25 Million | Australia | AU$0.04 | +2.94% | -2.78% | 80.75 Million |
| 717 |
PolyPid
NASDAQ:PYPD |
$77.73 Million | $77.73 Million | USA | $4.66 | -0.11% | +0.87% | 3.55 Million |
| 718 |
Aerovate Therapeutics Inc
NASDAQ:AVTE |
$77.68 Million | $77.68 Million | USA | $2.68 | +0.00% | +0.00% | 1.03 Million |
| 719 |
MAIA Biotechnology Inc.
NYSE MKT:MAIA |
$77.66 Million | $77.66 Million | USA | $1.28 | +0.00% | -5.88% | 12.98 Million |
| 720 |
Fluoguide AS
ST:FLUO |
$77.42 Million | Skr719.37 Million | Sweden | Skr44.00 | +0.00% | -5.38% | 141.70K |
| 721 |
ORIENTBIO Inc.
KO:002630 |
$76.42 Million | ₩112.77 Billion | Korea | ₩951.00 | -4.52% | +96.89% | 19.05 Million |
| 722 |
Gain Therapeutics Inc
NASDAQ:GANX |
$76.35 Million | $76.35 Million | USA | $1.79 | +2.29% | +5.92% | 16.55 Million |
| 723 |
Inovio Pharmaceuticals Inc
NASDAQ:INO |
$76.26 Million | $76.26 Million | USA | $1.11 | +0.91% | +1.83% | 49.50 Million |
| 724 |
ONDINE BIOMEDICAL INC.CDI
F:VF5 |
$75.33 Million | €64.44 Million | Germany | €0.15 | +14.62% | +16.41% | 0.00 |
| 725 |
Nyrada Inc
AU:NYR |
$74.53 Million | AU$105.33 Million | Australia | AU$0.43 | -2.27% | -12.24% | 6.11 Million |
| 726 |
Shanghai Haohai Biological Technology Co. Ltd
F:5HB |
$74.52 Million | €63.74 Million | Germany | €1.78 | +1.71% | -3.78% | 0.00 |
| 727 |
Rani Therapeutics Holdings Inc
NASDAQ:RANI |
$74.11 Million | $74.11 Million | USA | $0.76 | -1.09% | -9.52% | 26.05 Million |
| 728 |
LeonaBio, Inc.
NASDAQ:LONA |
$74.02 Million | $74.02 Million | USA | $7.88 | -6.75% | -8.27% | 800.24K |
| 729 |
Eyenovia Inc
NASDAQ:EYEN |
$73.30 Million | $73.30 Million | USA | $14.36 | -9.23% | +50.37% | 92.97 Million |
| 730 |
Lytix Biopharma AS
OL:LYTIX |
$72.99 Million | Nkr693.64 Million | Norway | Nkr9.02 | -3.63% | -6.63% | 1.16 Million |
| 731 |
Heron Therapeuti
NASDAQ:HRTX |
$72.30 Million | $72.30 Million | USA | $0.38 | -5.47% | -15.78% | 94.27 Million |
| 732 |
XBiotech Inc
NASDAQ:XBIT |
$71.65 Million | $71.65 Million | USA | $2.35 | +0.00% | -0.84% | 637.96K |
| 733 |
Pliant Therapeutics Inc
NASDAQ:PLRX |
$71.21 Million | $71.21 Million | USA | $1.19 | +4.39% | +3.48% | 12.38 Million |
| 734 |
Alterity Therapeutics Ltd
NASDAQ:ATHE |
$70.69 Million | $70.69 Million | USA | $4.65 | +5.44% | +18.62% | 2.15 Million |
| 735 |
Adicet Bio Inc
NASDAQ:ACET |
$70.58 Million | $70.58 Million | USA | $7.76 | -4.32% | +7.48% | 2.38 Million |
| 736 |
Coeptis Therapeutics Inc
NASDAQ:COEP |
$68.21 Million | $68.21 Million | USA | $16.40 | +1.17% | +19.62% | 1.29 Million |
| 737 |
Island Pharmaceuticals Ltd
AU:ILA |
$67.58 Million | AU$95.51 Million | Australia | AU$0.36 | -2.74% | -4.05% | 9.82 Million |
| 738 |
SynAct Pharma AB
ST:SYNACT |
$66.53 Million | Skr618.22 Million | Sweden | Skr11.04 | -8.76% | -19.42% | 14.58 Million |
| 739 |
Oncopeptides AB
ST:ONCO |
$65.87 Million | Skr612.12 Million | Sweden | Skr1.61 | -4.06% | -6.36% | 277.22 Million |
| 740 |
Alterity Therapeutics Limited
F:PBN |
$65.25 Million | €55.81 Million | Germany | €0.30 | +4.11% | +5980.00% | 0.00 |
| 741 |
Kazia Therapeutics Ltd ADR
NASDAQ:KZIA |
$64.84 Million | $64.84 Million | USA | $11.82 | +2.52% | +18.20% | 5.85 Million |
| 742 |
Sangamo Therapeutics Inc
NASDAQ:SGMO |
$64.67 Million | $64.67 Million | USA | $0.17 | +5.45% | +1.10% | 48.97 Million |
| 743 |
MediciNova Inc
NASDAQ:MNOV |
$64.38 Million | $64.38 Million | USA | $1.31 | +4.80% | +0.77% | 877.07K |
| 744 |
eXoZymes, Inc.
NASDAQ:EXOZ |
$62.91 Million | $62.91 Million | USA | $7.42 | +0.95% | -13.92% | 133.04K |
| 745 |
LTR Pharma Ltd
AU:LTP |
$62.38 Million | AU$88.16 Million | Australia | AU$0.49 | -6.73% | +4.30% | 12.23 Million |
| 746 |
Annovis Bio Inc
NYSE:ANVS |
$62.02 Million | $62.02 Million | USA | $1.79 | +0.56% | +0.00% | 29.39 Million |
| 747 |
Maat Pharma SA
PA:MAAT |
$61.82 Million | €52.88 Million | France | €2.82 | -3.75% | +2.17% | 3.78 Million |
| 748 |
ENTERA BIO IS-0000769
F:5DT |
$61.53 Million | €52.63 Million | Germany | €1.00 | -2.91% | -0.99% | 0.00 |
| 749 |
BeyondSpring Inc
NASDAQ:BYSI |
$61.27 Million | $61.27 Million | USA | $1.60 | -3.03% | -5.88% | 581.08K |
| 750 |
ImmunoPrecise Antibodies Ltd.
NASDAQ:HYFT |
$61.17 Million | $61.17 Million | USA | $1.47 | -5.77% | -8.13% | 13.06 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries